Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2026-02-25 @ 4:49 PM
Study NCT ID:
NCT02685267
Status:
TERMINATED
Last Update Posted:
2021-04-09
First Post:
2016-02-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer
Sponsor:
Prostate Cancer Clinical Trials Consortium
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02
Start Date Type:
None
Primary Completion Date:
2017-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-09
First Submit QC Date:
None
Study First Post Date:
2016-02-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-07-29
Results First Submit QC Date:
None
Results First Post Date:
2021-03-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-11
Last Update Post Date:
2021-04-09
Last Update Post Date Type:
ACTUAL